Cancer Risk in Patients with Hashimoto's Thyroiditis: a Nationwide Cohort Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 2013 Oct 3

PMID 24084773

Citations 47

Authors

Y-K Chen

C-L Lin

F T-F Cheng

F-C Sung

C-H Kao

Affiliations

Soon will be listed here.

Abstract

Background: This study examined the risk of cancer in patients with Hashimoto's thyroiditis (HT).

Methods: The Taiwanese National Health Insurance Research Database (NHIRD) was used to identify 1521 newly diagnosed HT patients from 1998-2010, and 6084 frequency-matched non-HT patients. The risk of developing cancer for HT patients was measured using the Cox proportional hazard model.

Results: The incidence of developing cancer in the HT cohort was 5.07 per 1000 person-years, which was 1.68-fold higher than that in the comparison cohort (P<0.001). Compared with patients aged 20-34 years, patients in older age groups had a higher risk of developing cancer (35-55 years: hazard ratio (HR)=5.96; >55 years: HR=9.66). After adjusting for sex, age, and comorbidities, the HT cohort had HRs of 4.76 and 11.8 for developing colorectal cancer and thyroid cancer, respectively, compared with non-HT cohort. Furthermore, the HT cohort to non-HT cohort incidence rate ratio (IRR) of thyroid cancer was higher in the first 3 years (48.4, 95% confidence interval (CI)=35.0-66.3), with an adjusted HR of 49.4 (95% CI=6.39-382.4).

Conclusion: Hashimoto's thyroiditis patients have a higher risk of thyroid cancer and colorectal cancer. The thyroid cancer prevention effort should start soon after HT is diagnosed, while being cautious of colorectal cancer increases with time.

Citing Articles

Causal relationship between antihypertensive drugs and Hashimoto's thyroiditis: a drug-target Mendelian randomization study.

Cui B, Chen A, Xu C, Mao C, Chen Y Front Endocrinol (Lausanne). 2024; 15:1419346.

PMID: 39435355 PMC: 11491371. DOI: 10.3389/fendo.2024.1419346.

Navigating the thyroid-gynecologic interplay: a systematic review and meta-analysis.

Ramadan H Obstet Gynecol Sci. 2024; 67(6):525-533.

PMID: 39317987 PMC: 11581810. DOI: 10.5468/ogs.24185.

The association of common autoimmune diseases with autoimmune thyroiditis: a two-sample Mendelian randomization study.

Zhang K, Luo Z, Wang X Front Endocrinol (Lausanne). 2024; 15:1383221.

PMID: 39314521 PMC: 11416997. DOI: 10.3389/fendo.2024.1383221.

Editorial: Molecular characterization of thyroid lesions in the era of "next generation" techniques: volume II.

Malapelle U, Bellevicine C, Friedlaender A, Ciarrocchi A, de Biase D Front Endocrinol (Lausanne). 2024; 15:1460239.

PMID: 39135622 PMC: 11317369. DOI: 10.3389/fendo.2024.1460239.

Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.

Kotwal A, Vance K, Hajric K, Yuil-Valdes A, Swanson B, Martinez Duarte E Thyroid. 2024; 34(8):999-1006.

PMID: 38916182 PMC: 11564831. DOI: 10.1089/thy.2024.0072.

References

Guarino V, Castellone M, Avilla E, Melillo R . Thyroid cancer and inflammation. Mol Cell Endocrinol. 2009; 321(1):94-102. DOI: 10.1016/j.mce.2009.10.003. View

Nose F, Ichikawa T, Fujiwara M, Okayasu I . Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol. 2002; 117(4):546-51. DOI: 10.1309/9CCJ-XQ8P-PMFM-M65K. View

Larson S, Jackson L, Riall T, Uchida T, Thomas R, Qiu S . Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007; 204(5):764-73. PMC: 2430882. DOI: 10.1016/j.jamcollsurg.2006.12.037. View

Segal K, Ben-Bassat M, Avraham A, Har-El G, SIDI J . Hashimoto's thyroiditis and carcinoma of the thyroid gland. Int Surg. 1985; 70(3):205-9. View

Sano H, Kawahito Y, Wilder R, Hashiramoto A, Mukai S, Asai K . Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995; 55(17):3785-9. View

Repplinger D, Bargren A, Zhang Y, Adler J, Haymart M, Chen H . Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?. J Surg Res. 2007; 150(1):49-52. PMC: 2575056. DOI: 10.1016/j.jss.2007.09.020. View

Pisanu A, Piu S, Cois A, Uccheddu A . Coexisting Hashimoto's thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy. Chir Ital. 2003; 55(3):365-72. View

Maruchi N, Annegers J, Kurland L . Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc. 1976; 51(5):263-5. View

Holm L, Blomgren H, Lowhagen T . Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985; 312(10):601-4. DOI: 10.1056/NEJM198503073121001. View

10.

Hyjek E, Isaacson P . Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988; 19(11):1315-26. DOI: 10.1016/s0046-8177(88)80287-9. View

11.

MACKSOOD W, RAPPORT R, Hodges F . The increasing incidence of Hashimoto's disease. Arch Surg. 1961; 83:384-7. DOI: 10.1001/archsurg.1961.01300150058007. View

12.

Muller I, Pinchera A, Fiore E, Belardi V, Rosellini V, Giustarini E . High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest. 2010; 34(5):349-52. DOI: 10.1007/BF03347458. View

13.

Ahn D, Heo S, Park J, Kim J, Sohn J, Park J . Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol. 2011; 50(8):1228-34. DOI: 10.3109/0284186X.2011.602109. View

14.

Yamashita N, Maruchi N, Mori W . Hashimoto's thyroiditis: a possible risk factor for lung cancer among Japanese women. Cancer Lett. 1979; 7(1):9-13. DOI: 10.1016/s0304-3835(79)80070-1. View

15.

Eberhart C, Coffey R, Radhika A, Giardiello F, Ferrenbach S, DuBois R . Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994; 107(4):1183-8. DOI: 10.1016/0016-5085(94)90246-1. View

16.

Eisenberg B, Hensley S . Thyroid cancer with coexistent Hashimoto's thyroiditis. Clinical assessment and management. Arch Surg. 1989; 124(9):1045-7. DOI: 10.1001/archsurg.1989.01410090055012. View

17.

Anil C, Goksel S, Gursoy A . Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid. 2010; 20(6):601-6. DOI: 10.1089/thy.2009.0450. View

18.

Dayan C, Daniels G . Chronic autoimmune thyroiditis. N Engl J Med. 1996; 335(2):99-107. DOI: 10.1056/NEJM199607113350206. View

19.

Ito K, Maruchi N . Breast cancer in patients with Hashimoto's thyroiditis. Lancet. 1975; 2(7945):1119-21. DOI: 10.1016/s0140-6736(75)91006-5. View

20.

Di Pasquale M, Rothstein J, Palazzo J . Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. Hum Pathol. 2001; 32(1):24-30. DOI: 10.1053/hupa.2001.21138. View